machine learning prediction of 5-year all-cause mortality in non-dialysis chronic kidney disease patients
Source article: Machine learning-assisted prediction of 5-year mortality in chronic kidney disease: the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD)
Abstract: Mortality prediction models for patients with non-dialysis chronic kidney disease (CKD) remain limited despite their clinical importance. While machine learning (ML) offers the potential to improve prediction accuracy, its "black-box" nature has hindered clinical adoption. This study aimed to develop and validate an interpretable ML model for predicting 5-year all-cause mortality in patients with non-dialysis CKD and to deploy it as a user-friendly web-based risk stratification tool. We analyzed 1,858 patients (…
Contested: both sides are scored from claims and sources, not community votes.

"Kidney Dialysis Center at the IBB Specialist Hospital,Minna, Niger State, Nigeria" by InfantjournalistMMB is licensed under CC BY 4.0. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
Researchers developed and validated an interpretable machine learning model to predict 5-year all-cause mortality in non-dialysis chronic kidney disease using data from 1,858 patients in the KNOW-CKD prospective cohort, with 94 deaths observed. The CatBoost model achieved AUC 0.813 versus 0.747 for logistic regression, and a simplified version using age, eGFR, albumin, urine protein-to-creatinine ratio, and total calcium retained AUC 0.795 in an external cohort of 348 patients.
The work matters because accurate mortality risk stratification could guide earlier personalized management in a population where prediction tools remain limited, and the use of SHAP to surface five routine labs plus a U-shaped calcium risk makes the tool more clinically usable. Uncertainty remains about generalizability beyond Korean cohorts, performance with only 94 events, and whether web-based deployment will translate into changed care or outcomes.
- Study analyzed 1,858 patients (94 deaths) from prospective KNOW-CKD cohort of non-dialysis CKD patients.
- Simplified model used top-5 SHAP-ranked features: age, estimated glomerular filtration rate, serum albumin, spot urine protein-to-creatinine ratio, and serum total calcium.
- External validation performed in independent cohort of 348 CKD patients with AUC 0.795.
- SHAP visualization revealed U-shaped relationship for serum calcium, identifying hypocalcemia as under-recognized mortality risk factor.
A CatBoost model trained on 1,858 non-dialysis CKD patients predicted 5-year all-cause mortality with AUC 0.813, outperforming logistic regression, and a simplified 5-feature version maintained AUC 0.795 in external validation.
Machine learning's black-box nature has hindered clinical adoption of mortality prediction models for non-dialysis CKD despite their clinical importance.
The rundown
Researchers trained several ML algorithms including CatBoost and compared them to conventional logistic regression on 1,858 KNOW-CKD participants, using SHapley Additive exPlanations to rank features and improve interpretability, then built a simplified model from the top five features.
The simplified model was externally validated in 348 patients and deployed as a user-friendly web-based risk stratification tool intended to enable early risk stratification and personalized management in non-dialysis CKD care.
Sources
- Peer-reviewedKidney Research and Clinical Practice2026-08-07
How should this claim be treated?
ace
The debate